Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
21.80
+0.79 (3.76%)
At close: Feb 6, 2026, 4:00 PM EST
21.54
-0.26 (-1.19%)
After-hours: Feb 6, 2026, 7:13 PM EST
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $1.17 billion as of February 6, 2026. Its market cap has increased by 234.15% in one year.
Market Cap
1.17B
Enterprise Value
880.12M
1-Year Change
234.15%
Ranking
Category
Stock Price
$21.80
Market Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has increased from $676.47M to $1.17B, an increase of 72.99%. That is a compound annual growth rate of 47.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 1.17B | -39.96% |
| Dec 31, 2025 | 1.95B | 469.46% |
| Dec 31, 2024 | 342.27M | -49.40% |
| Sep 13, 2024 | 676.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Capricor Therapeutics | 1.19B |
| Inhibrx Biosciences | 1.19B |
| Immatics | 1.15B |
| Inventiva | 1.15B |
| Xeris Biopharma Holdings | 1.15B |
| Pharming Group | 1.13B |
| Compass Therapeutics | 1.11B |
| Septerna | 1.09B |